These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 26938440)

  • 1. The Biology of Huntingtin.
    Saudou F; Humbert S
    Neuron; 2016 Mar; 89(5):910-26. PubMed ID: 26938440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurobiology of Huntington's Disease.
    De Souza RA; Leavitt BR
    Curr Top Behav Neurosci; 2015; 22():81-100. PubMed ID: 25205327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions.
    Davranche A; Aviolat H; Zeder-Lutz G; Busso D; Altschuh D; Trottier Y; Klein FA
    Hum Mol Genet; 2011 Jul; 20(14):2795-806. PubMed ID: 21518730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential sequence of the N-terminal cytoplasmic localization-related domain of huntingtin and its effect on huntingtin aggregates.
    Yan Y; Peng D; Tian J; Chi J; Tan J; Yin X; Pu J; Xia K; Zhang B
    Sci China Life Sci; 2011 Apr; 54(4):342-50. PubMed ID: 21509658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translating Antisense Technology into a Treatment for Huntington's Disease.
    Lane RM; Smith A; Baumann T; Gleichmann M; Norris D; Bennett CF; Kordasiewicz H
    Methods Mol Biol; 2018; 1780():497-523. PubMed ID: 29856033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained effects of nonallele-specific Huntingtin silencing.
    Drouet V; Perrin V; Hassig R; Dufour N; Auregan G; Alves S; Bonvento G; Brouillet E; Luthi-Carter R; Hantraye P; Déglon N
    Ann Neurol; 2009 Mar; 65(3):276-85. PubMed ID: 19334076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Huntington's disease: cellular and molecular basis of pathology].
    Korzhova VV; Artamonov DN; Vlasova OL; Bezprozvannyĭ IB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2014; 64(4):359-75. PubMed ID: 25723022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calretinin interacts with huntingtin and reduces mutant huntingtin-caused cytotoxicity.
    Dong G; Gross K; Qiao F; Ferguson J; Callegari EA; Rezvani K; Zhang D; Gloeckner CJ; Ueffing M; Wang H
    J Neurochem; 2012 Nov; 123(3):437-46. PubMed ID: 22891683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological polyQ expansion does not alter the conformation of the Huntingtin-HAP40 complex.
    Huang B; Guo Q; Niedermeier ML; Cheng J; Engler T; Maurer M; Pautsch A; Baumeister W; Stengel F; Kochanek S; Fernández-Busnadiego R
    Structure; 2021 Aug; 29(8):804-809.e5. PubMed ID: 33909994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
    Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B
    J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational investigation of molecular mechanism and neuropathological implications in Huntington disease.
    Gopalakrishnan C; Kalsi N; Jethi S; Purohit R
    Mol Cell Biochem; 2015 Nov; 409(1-2):1-11. PubMed ID: 26369532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of flanking sequences and cellular context on subcellular behavior and pathology of mutant HTT.
    Chongtham A; Bornemann DJ; Barbaro BA; Lukacsovich T; Agrawal N; Syed A; Worthge S; Purcell J; Burke J; Chin TM; Marsh JL
    Hum Mol Genet; 2020 Mar; 29(4):674-688. PubMed ID: 31943010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer: From Wild-Type to Mutant Huntingtin.
    Thion MS; Humbert S
    J Huntingtons Dis; 2018; 7(3):201-208. PubMed ID: 29889077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protein-Protein Interactions of Huntingtin in the Hippocampus].
    Proskura AL; Vechkapova SO; Zapara TA; Ratushniak AS
    Mol Biol (Mosk); 2017; 51(4):734-742. PubMed ID: 28900094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chaperone protein HYPK interacts with the first 17 amino acid region of Huntingtin and modulates mutant HTT-mediated aggregation and cytotoxicity.
    Choudhury KR; Bhattacharyya NP
    Biochem Biophys Res Commun; 2015 Jan; 456(1):66-73. PubMed ID: 25446099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant palmitoylation in Huntington disease.
    Sanders SS; Hayden MR
    Biochem Soc Trans; 2015 Apr; 43(2):205-10. PubMed ID: 25849918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein aggregates in Huntington's disease.
    Arrasate M; Finkbeiner S
    Exp Neurol; 2012 Nov; 238(1):1-11. PubMed ID: 22200539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Huntington disease in Drosophila: Insights into axonal transport defects and modifiers of toxicity.
    Krench M; Littleton JT
    Fly (Austin); 2013; 7(4):229-36. PubMed ID: 24022020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner.
    Benn CL; Sun T; Sadri-Vakili G; McFarland KN; DiRocco DP; Yohrling GJ; Clark TW; Bouzou B; Cha JH
    J Neurosci; 2008 Oct; 28(42):10720-33. PubMed ID: 18923047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of the first 17 amino acids of huntingtin in Huntington's disease.
    Arndt JR; Chaibva M; Legleiter J
    Biomol Concepts; 2015 Mar; 6(1):33-46. PubMed ID: 25741791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.